PSMAAddition: An International Prospective Open-label, Randomized, Phase III Study comparing 177LU-PSMA-617 in combination with Standard of Care, versus Standard of Care alone, in adult make patients with Metastatic Hormone Sensitive Prostate Cancer
ENROLLING
Trial ID:
NCT04720157 Protocol # :
22-543
Phase
III
Disease Sites
Prostate
Principal Investigator
Ravi, Praful, Kumar
Site Research Nurses
Bretta, Katherine, v.
Carey, Margaret, M.
Creaton, Eileen
Healy, Erin, C.
Kabarame, Liliane
Katica, Dean
Kelleher, Kaitlin
Kelleher, Kaitlin
Leisner, Claire
Mingrino, Sage
Prisby, Judith
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #22-543
22-543